Skip to content

Harish Doppalapudi

NPI 1841403581ActiveIndividual· Internal Medicine, Clinical Cardiac Electrophysiology· Birmingham, AL

Internal Medicine, Clinical Cardiac Electrophysiology in Birmingham, Alabama, licensed in AL, with an NPI issued in May 2007. Part D covered 84 prescriptions written in 2024, 87% of them generic. Abbott Laboratories was the largest of 2 companies reporting payments in 2025, $873.12 in all, mostly travel and lodging.

Overview

NPI1841403581
StatusActive
Entity typeIndividual
Sole proprietorNo
NPI issuedMay 8, 2007
Last updated in NPPESJun 28, 2023

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Cardiac Electrophysiology (AL)

Part D prescriptions in 2024

Prescriptions (claims)84 · 206 30-day fills
Total drug cost$6,256
Generic share87% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$873.12 · 5 payments from 2 companies
  • 2024$3,044 · 19 payments from 1 company

Top paying companies in 2025

CompanyAmountPayments
Abbott Laboratories$742.474
Boston Scientific Corporation$130.651

What the 2025 payments were for

  • Travel and Lodging$742.47 · 4 payments
  • Food and Beverage$130.65 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Clinical Cardiac Electrophysiology providers in Birmingham

All Internal Medicine, Clinical Cardiac Electrophysiology providers in Alabama →